⌘K
Loading ticker…
Olema Pharmaceuticals, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Olema Pharmaceuticals, Inc. Common Stock (OLMA) has a 3-month relative strength percentile of 18 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.7%, relative volume 3.03×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
18 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
OLMA is held by 5 ETFs as of Mar 2026. Top owner: XBI at 0.50% weight, $37M notional. Top 3 carry $98M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.50% | $37M |
| VTIVanguard Total Stock Market ETF | 0.00% | $36M |
| IWMiShares Russell 2000 ETF | 0.04% | $25M |
| VXFVanguard Extended Market ETF | 0.01% | $9M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OLMA Jan avg: 24.44% median: 3.84% win: 75% σ: 48.74% n: 4 2022-04-12 → 2026-05-29 | OLMA Feb avg: -13.60% median: -10.51% win: 0% σ: 10.93% n: 4 2022-04-12 → 2026-05-29 | OLMA Mar avg: -19.11% median: -14.66% win: 0% σ: 13.17% n: 4 2022-04-12 → 2026-05-29 | OLMA Apr avg: 7.67% median: -3.35% win: 40% σ: 28.30% n: 5 2022-04-12 → 2026-05-29 | OLMA May avg: 1.83% median: 2.33% win: 60% σ: 8.58% n: 5 2022-04-12 → 2026-05-29 | OLMA Jun avg: 27.36% median: 27.04% win: 75% σ: 40.34% n: 4 2022-04-12 → 2026-05-29 (current) | OLMA Jul avg: 22.29% median: 22.00% win: 75% σ: 21.90% n: 4 2022-04-12 → 2026-05-29 | OLMA Aug avg: -6.18% median: -7.54% win: 50% σ: 21.36% n: 4 2022-04-12 → 2026-05-29 | OLMA Sep avg: 18.01% median: 11.43% win: 75% σ: 46.08% n: 4 2022-04-12 → 2026-05-29 | OLMA Oct avg: 8.01% median: 2.09% win: 50% σ: 19.97% n: 4 2022-04-12 → 2026-05-29 | OLMA Nov avg: 46.20% median: -3.63% win: 50% σ: 113.63% n: 4 2022-04-12 → 2026-05-29 | OLMA Dec avg: -17.04% median: -13.18% win: 25% σ: 18.14% n: 4 2022-04-12 → 2026-05-29 |